An observational study in Iron Deficiency Anemia and Inflammation, sponsored by Swiss Federal Institute of Technology. Completed at 1 site in Morocco. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-22.
Sponsored by Swiss Federal Institute of Technology · Observational
During inflammation hepcidin concentrations are increased, leading to a decrease in iron absorption. In iron deficiency anemia hepcidin is suppressed due to the activation of erythropoiesis. Whether inflammation or anemia has the stronger effect on hepcidin is uncertain.
1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.
This study's enrollment of 50 is below the median of 200 across 326 observational studies indexed under Anemia.
Browse Anemia studies →Swiss Federal Institute of Technology is the lead sponsor of 152 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Young women with or without iron-deficiency anemia
Exclusion Criteria:
Biological: Dultavax and Vaxigrip
anemia due to iron deficiency
Biological: Dultavax and Vaxigrip
All the women got an influenza/DTP vaccine in order to induce acute inflammation
Fractional and total iron absorption
Time frame: 14 days after the second baseline test meal administration
Fractional and total iron absorption
Time frame: 14 days after the test meal administered 24 hours after vaccination
Serum hepcidin
Time frame: up to 36 hours
Serum Interleukin 6
inflammation
Time frame: up to 36 hours
Serum ferritin
Iron status
Time frame: up to 36 hours
Serum transferrin
Iron status
Time frame: up to 36 hours
Serum CRP
inflammation
Time frame: up to 36 hours
Serum AGP
inflammation
Time frame: up to 36 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Swiss Federal Institute of Technology